Outlook Therapeutics, Inc.

General ticker "OTLK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $54.2M (TTM average)

Outlook Therapeutics, Inc. follows the US Stock Market performance with the rate: 2.6%.

Estimated limits based on current volatility of 5.4%: low 1.79$, high 1.99$

Factors to consider:

  • Total employees count: 83 as of 2016
  • Current price 16.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [3.13$, 10.29$]
  • 2025-09-30 to 2026-09-30 estimated range: [2.47$, 8.28$]

Financial Metrics affecting the OTLK estimates:

  • Positive: with PPE of -1.4 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -64.80 <= 0.33
  • Positive: Investing cash flow per share per price, % of 0 > -0.66
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -20.43 <= 0
  • Negative: Shareholder equity ratio, % of -253.53 <= 18.93

Similar symbols

Short-term OTLK quotes

Long-term OTLK plot with estimates

Financial data

YTD 2022-09-30 2023-09-30 2024-09-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $63.07MM $53.13MM $71.70MM
Operating Income $-63.07MM $-53.13MM $-71.70MM
Non-Operating Income $-2.98MM $-5.85MM $-3.66MM
Interest Expense $1.49MM $1.56MM $3.16MM
R&D Expense $42.33MM $26.45MM $41.76MM
Income(Loss) $-66.05MM $-58.98MM $-75.36MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss)* $-66.05MM $-58.98MM $-75.37MM
Stockholders Equity $8.74MM $-14.44MM $-73.08MM
Assets $28.53MM $32.30MM $28.82MM
Operating Cash Flow $-56.67MM $-42.97MM $-68.79MM
Financing Cash Flow $59.59MM $48.97MM $60.33MM
Earnings Per Share** $-6.23 $-4.72 $-4.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.